-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TSL-1502 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TSL-1502 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TSL-1502 in Triple-Negative Breast Cancer (TNBC) Drug Details:TSL-1502 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TSL-1502 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TSL-1502 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TSL-1502 in Human...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CBP-1019 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CBP-1019 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CBP-1019 in Solid Tumor Drug Details: CBP-1019 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Neratinib in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Neratinib in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neratinib in Melanoma Drug Details: Neratinib (Nerlynx) is a member of the 4-anilino...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TSL-1502
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TSL-1502 Drug Details TSL-1502 is under development for the treatment of solid tumor, HER2-...